6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
424B3: Prospectus
424B3: Prospectus
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
SC 13D: Statement of acquisition of beneficial ownership by individuals-The Biotech Company LLC(7.8%),Gastón Paladini(7.8%)
Moolec | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bioceres Group PLC(33.2%),THEO I SCSp(31.6%)
Moolec | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Moolec | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Moolec | 424B3: Prospectus
Moolec | 424B3: Prospectus
Moolec | 6-K: Report of foreign private issuer (related to financial reporting)
Moolec | 424B3: Prospectus
Moolec | 424B3: Prospectus
Moolec | EFFECT: Others
Moolec | EFFECT: Others
Moolec | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Moolec | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Moolec | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Moolec | 20-F: FY2023 Annual Report
No Data